I'm Melanie Avalon, and I have a very special guest with us here today
On GLP-1 weight management: the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health, has documented that GLP-1 receptor agonists support weight reduction in adults with obesity or overweight with weight-related comorbidities when combined with reduced-calorie diet and increased physical activity
That does not mean other pharmacies are bad
When she checks in on your progress she helps you make adjustments as needed
The stopping GLP-1s guide uses four restart signals: more than 5% regain over eight weeks despite protocol adherence, rebounding visceral-fat markers, HbA1c above the pre-drug baseline, or declining strength
This is because GLP-1 medications can slow down the emptying of the gallbladder, which can lead to the formation of gallstones